Cite
Murciano-Goroff YR, Pak T, Mondaca S, et al. Immune biomarkers and response to checkpoint inhibition of BRAF. Br J Cancer. 2021;doi: 10.1038/s41416-021-01679-1.
Murciano-Goroff, Y. R., Pak, T., Mondaca, S., Flynn, J. R., Montecalvo, J., Rekhtman, N., Halpenny, D., Plodkowski, A. J., Wu, S. L., Kris, M. G., Paik, P. K., Riely, G. J., Yu, H. A., Rudin, C. M., Hellmann, M. D., Land, J. D., Buie, L. W., Heller, G., Lito, P., Yaeger, R., Drilon, A., Liu, D., Li, B. T., & Offin, M. (2021). Immune biomarkers and response to checkpoint inhibition of BRAF. British journal of cancer, . https://doi.org/10.1038/s41416-021-01679-1
Murciano-Goroff, Yonina R, et al. "Immune biomarkers and response to checkpoint inhibition of BRAF." British journal of cancer vol. (2021). doi: https://doi.org/10.1038/s41416-021-01679-1
Murciano-Goroff YR, Pak T, Mondaca S, Flynn JR, Montecalvo J, Rekhtman N, Halpenny D, Plodkowski AJ, Wu SL, Kris MG, Paik PK, Riely GJ, Yu HA, Rudin CM, Hellmann MD, Land JD, Buie LW, Heller G, Lito P, Yaeger R, Drilon A, Liu D, Li BT, Offin M. Immune biomarkers and response to checkpoint inhibition of BRAF. Br J Cancer. 2021 Dec 28; doi: 10.1038/s41416-021-01679-1. Epub 2021 Dec 28. PMID: 34963703.
Copy
Download .nbib